Kookmin Bio is a biotechnology company that specialises in the development of bio-food and pharmaceutical materials.
Kookmin Bio has raised $2.4M in total funding. The most recent round was Series B. The last funding was announced in November 2024.
Kookmin Bio's investors include New Paradigm Investment, Industrial Bank of Korea, K Ground Ventures, Korea Alternative Investment Asset Management, KMU Holdings.
Kookmin Bio is headquartered in Jeonju, South Korea.
Kookmin Bio is a biotechnology company that specialises in the development of bio-food and pharmaceutical materials.
Kookmin Bio is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kookmin Bio — Funding & Investors." VCBacked, November 20, 2024, https://www.vcbacked.co/company/kookmin-bio. Accessed August 1, 2026.
VCBacked. (2024). Kookmin Bio — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/kookmin-bio
{{cite web |title=Kookmin Bio — Funding & Investors |url=https://www.vcbacked.co/company/kookmin-bio |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated